{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-013743","form_type":"8-K","ticker":"NHTC","cik":"0000912061","company_name":"NATURAL HEALTH TRENDS CORP","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.921646+00:00","generated_at":"2026-05-15T02:37:29.744630+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NHTC Q1 2026 revenue $9.2M, down 14% YoY; net loss $154k vs prior year income","bullets":["Revenue $9.2M, down 6% from Q4 2025 and 14% from Q1 2025.","Net loss $154k ($0.02 diluted EPS) vs net income $122k ($0.01) in Q1 2025.","Operating loss $474k; restructuring savings of ~$300k in the quarter.","Active members 26,400, down from 30,180 a year ago.","Declared $0.10/share quarterly dividend payable May 22, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-013743","json":"https://secwatch.observer/filing/0001437749-26-013743.json","markdown":"https://secwatch.observer/filing/0001437749-26-013743.md","text":"https://secwatch.observer/filing/0001437749-26-013743.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/912061/000143774926013743/0001437749-26-013743-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/912061/000143774926013743/nhtc20260306_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:37:29.744630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"055e719105a657e157cc942595509f0537416213","claim":"NATURAL HEALTH TRENDS CORP reported the quarter ended March 31, 2026 results: revenue $9.2 million, net income $154,000, EPS $0.02 per diluted share.","evidence_excerpt":"First Quarter 2026 Financial Highlights • Revenue of $9.2 million decreased 6% compared to $9.7 million in the fourth quarter of 2025 and declined 14% compared to $10.7 million in the first quarter of 2025. • Operating loss was $474,000 compared to $635,000 in the fourth quarter of 2025 and $345,000 in the first quarter of 2025. • Net loss was $154 ,000, or $0.02 per diluted share, compared to $588,000, or $0.05 per diluted share, in the fourth quarter of 2025 and net income of $122,000, or $0.01 per diluted share, in the first quarter of 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/912061/000143774926013743/0001437749-26-013743-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Revenue","value":"$9.2 million"},{"label":"Net income","value":"$154,000"},{"label":"EPS","value":"$0.02 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}